GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aquarius Surgical Technologies Inc (OTCPK:AQQRF) » Definitions » YoY EBITDA Growth

Aquarius Surgical Technologies (Aquarius Surgical Technologies) YoY EBITDA Growth : 50.00% (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Aquarius Surgical Technologies YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Aquarius Surgical Technologies's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was 50.00%.

Aquarius Surgical Technologies's EBITDA per Share for the three months ended in Dec. 2023 was $-0.00.


Aquarius Surgical Technologies YoY EBITDA Growth Historical Data

The historical data trend for Aquarius Surgical Technologies's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aquarius Surgical Technologies YoY EBITDA Growth Chart

Aquarius Surgical Technologies Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 83.89 22.92 -24.32 54.35 28.57

Aquarius Surgical Technologies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -50.00 83.33 40.00 25.00 50.00

Aquarius Surgical Technologies YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Aquarius Surgical Technologies's YoY EBITDA Growth for the fiscal year that ended in Mar. 2023 is calculated as:

YoY EBITDA Growth (A: Mar. 2023 )
=(EBITDA per Share (A: Mar. 2023 )-EBITDA per Share (A: Mar. 2022 ))/ | EBITDA per Share (A: Mar. 2022 ) |
=(-0.015--0.021)/ | -0.021 |
=28.57 %

Aquarius Surgical Technologies's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (Q: Dec. 2023 )
=(EBITDA per Share (Q: Dec. 2023 )-EBITDA per Share (Q: Dec. 2022 )) / | EBITDA per Share (Q: Dec. 2022 )) |
=(-0.003--0.006)/ | -0.006 |
=50.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aquarius Surgical Technologies YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Aquarius Surgical Technologies's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Aquarius Surgical Technologies (Aquarius Surgical Technologies) Business Description

Traded in Other Exchanges
Address
89 Scollard Street, Toronto, ON, CAN, M5R 1G4
Aquarius Surgical Technologies Inc is engaged in the development, sale, distribution, marketing, and exploitation of laser-driven technologies for use in surgical environments, principally in the field of urology. The company derives revenue from the sale of medical devices and fiber-optic delivery devices. Geographically, it has a presence in Canada, the United States, and the Dominican Republic.